During the past decade, Stony Brook University HSC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Stony Brook University HSC" are "Acute Pain" (1 trials) and "Lacerations" (1 trials). Many other conditions were trialed in "Stony Brook University HSC" in a lesser frequency.

Most popular intervention types in "Stony Brook University HSC" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fentanyl 100 µg" (1 trials), "Fentanyl 200 µg" (1 trials), "Fentanyl 400 µg" (1 trials), "Intravenous Placebo" (1 trials) and "Morphine 6 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Stony Brook University HSC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Stony Brook University HSC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Stony Brook University HSC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Stony Brook University HSC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".